Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Trading Update

23 Jul 2009 07:00

RNS Number : 1435W
TyraTech, Inc.
23 July 2009
 



For immediate release

23 July 2009

There will be a conference call for investors and analysts to discuss this announcement today at 11:00 (BST). Dial-in details are as follows: UK Access Number: +44 (0)20 8609 1435, US toll free number: 1866 793 4279, PIN code: 356088#. A replay of the conference call will be available for one month via UK: 0800 358 2189 or 020 8609 0289, US: 1 866 676 5865. Conference reference number: 268811#.

TYRATECH, INC.

("TyraTech" or "the Company")

Trading Update

TyraTech, Inc. (AIM: TYR), a leading independent novel clean technology company for human, animal and environmental health, today provides an update on trading for the six month period ended 30 June 2009. The Company will announce its interim results on 16 September 2009. 

Product sales for the first half of 2009 continue to grow, supported particularly by the Company's first orders of insecticide by its new partner, Terminix. However, the Board anticipates that revenues and profits for the full year 2009 will be significantly below current market expectations. Cash balances are expected to be at or near market expectations at year end. The reduction in revenue projection ties to a reduced activity in certain low-margin business areas, and the difficulty in accurately forecasting the size and timing of new orders for the Company's major commercial businesses - notably its commercial partner Terminix and its Sustainable Solutions division - that are otherwise showing material sales growth. Directors' expectations of year end cash levels being near to, or at, current market expectations are due to improved working capital management and close operational management of expenses and have been arrived at, assuming revenue from contracts in hand or which are close to completion.

While additional contracts and orders are expected in 2009, the Company will communicate these developments to the market, when they are accurately known.

TyraTech's main commercial programs are progressing well. The development project with Kraft Foods is on track for 2009 and no reductions in revenue are expected. TyraTech's partnership with Terminix has developed ahead of schedule and has already led to two major product orders, the first of which has been delivered and the second of which is scheduled for the next few weeks. Terminix's marketing of the SafeShield insecticide product is only in the initial stages, and though underway, accurate forecasting of new orders is difficult until some experience is gained.

TyraTech's other partnerships with Arysta and TyraChem are continuing to develop well and the Company will provide guidance to the market as significant changes in revenue expectations occur.

One line of projected business revenue for 2009 was expected though the Company's commercial partner in India. Based on difficulties in getting payments and slow market development of what has been a low margin opportunity, TyraTech will no longer continue this commercial activity, and has included this decision in its revised guidance.

TyraTech's Sustainable Solutions business is progressing well with a significant amount of interest in the division's products. Revenues for the year are largely to come from the sales of its WasteSolver and SolidSolver equipment to dairy farms for effective waste management. Sales have been adversely affected largely due to the price of milk in the USA, which has dropped by 44% since January 2008, and dairy farmers are cautious about taking on new financial commitments. This situation has resulted in a reduction in the projected revenue for 2009. However, the level and rate of completed purchase contracts has increased in late Q2 2009, and the business is expected to show revenue growth through 2009 as new installations are commissioned. TyraTech has engaged advisors to explore bringing in a new strategic investor to further accelerate its rate of growth.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said: "In 2009, TyraTech has successfully demonstrated a transition from the development state to a growing commercial company with several product lines and market adoption. Revenues are on the rise led by our relationships with Terminix and Kraft Foods, along with the progress in our Sustainable Solutions Division. Our multiple paths of revenue business model is beginning to clearly be demonstrated.

"While the business operations have progressed well, we are cautious about how quickly our markets will expand and we are therefore carefully controlling our costs and working capital investments. We remain positive that we can execute our business plan and strategy and that there is potential for high gross margins on products and additional material payments from partnering and licensing deals. We believe that we will be able to evidence this progress through announcements during the rest of 2009 and we will carefully expand expectations as the business grows into 2010."

For further information please contact:

TyraTech Inc.
 
Douglas Armstrong Ph.D., Chief Executive Officer
+1 (321) 409 7723
Keith Bigsby, Chief Financial Officer
+1 (321) 409 7714
www.tyratech.com
 
Nomura Code Securities
 
Charles Walker / Clare Terlouw
+44 (0)20 7776 1200
www.nomuracode.com
 
Buchanan Communications
 
Mary-Jane Elliott / Lisa Baderoon
+44 (0)20 7466 5000
/ Catherine Breen / Stasa Filiplic
 
www.buchanan.uk.com
 

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

###

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPUUUAMUPBUCW
Date   Source Headline
14th Jan 20147:00 amRNSChange of Adviser
14th Jan 20147:00 amRNSVamousse coming to Walmart stores in the USA
18th Dec 20137:00 amRNSBlocklisting Interim Review
25th Oct 20132:39 pmRNSDirector/PDMR Shareholding
7th Oct 20138:39 amRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSInterim Results
14th Aug 20137:00 amRNSGlobal distribution agreement for biocide products
25th Jul 20136:11 pmRNSResult of AGM
27th Jun 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSDirectorate Changes
19th Jun 20139:59 amRNSBlocklisting Interim Review
11th Jun 20134:23 pmRNSDirectorate Change
31st May 201312:43 pmRNSMigration of Shares
11th Apr 20137:00 amRNSFrench Registration of Insect Repellent Product
9th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20136:09 pmRNSResult of Special Meeting
28th Mar 20134:15 pmRNSShare Migration
19th Mar 20137:00 amRNSAppointment of Financial PR and IR advisor
18th Mar 20137:00 amRNSProposed placing and subscription of common shares
4th Mar 20137:00 amRNSUK registration of insect repellent product
4th Feb 20137:00 amRNSFirst Patent Granted for ExtendT Technology
30th Jan 20137:00 amRNSAMVAC and TyraTech Name New Joint Venture
10th Jan 20137:00 amRNSDirectorate Change
7th Jan 201310:40 amRNSNew Anti-Endoparasitic Composition Patents
20th Dec 20127:00 amRNSIssue of Equity
18th Dec 20122:56 pmRNSBlocklisting Interim Review
18th Dec 20127:00 amRNSGerman Registration of Insect Repellent Product
17th Dec 20127:00 amRNSFirst Shipment of Retail Products
11th Dec 20127:00 amRNSHead Lice Product Registration in UK
4th Dec 20127:00 amRNSFormation of New Joint Venture
13th Nov 20127:00 amRNSU.S. Registration of New Insect Repellent Product
7th Nov 20122:10 pmRNSProactive Investors One2One Investor Forum
30th Oct 20127:00 amRNSAdvance Payment on Prospective New Alliance
29th Oct 20127:00 amRNSChange of Name of Adviser
16th Oct 201211:40 amRNSTyraTech Secures New Patent
16th Oct 20129:26 amRNSMigration of Shares
1st Oct 20127:00 amRNSInterim Results
28th Sep 20121:15 pmRNSInterim Results
26th Sep 20127:00 amRNSProducts to Launch at The Home Depot
25th Sep 20127:00 amRNSTrademark Licensing Agreement with Terminix
10th Aug 20123:02 pmRNSMigration of Shares
25th Jul 20123:55 pmRNSResult of AGM
6th Jul 20124:36 pmRNSMigration of Shares
2nd Jul 20121:18 pmRNSDirector/PDMR Shareholding
2nd Jul 201211:39 amRNSDirector/PDMR Shareholding
28th Jun 20127:00 amRNSFinal Results
18th Jun 20127:00 amRNSBlocklisting Interim Review
22nd May 20127:00 amRNSTrading Update
14th May 20127:00 amRNSIssue of Equity
10th May 20127:00 amRNSMigration of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.